Kaspar Draaisma - Concepedia

Author

Kaspar Draaisma

University Medical Center Utrecht ORCID

Also Known As

Draaisma, Kaspar, K Draaisma, K. Draaisma, Kaspar Draaisma

Publications

571

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht University of Liège Erasmus MC European Organisation for Research and Treatment of Cancer Erasmus MC Cancer Institute

About

Kaspar Draaisma is an author at University Medical Center Utrecht specializing in high-grade gliomas, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	253
2	Neuro-oncology	2	2	253
3	Cell Biology	1	1	231
4	Neurology	1	1	22
5	Systems Biology	1	1	231

Kaspar Draaisma

Publications

527

Citations

H-Index

Page 1

	Year	Citations
Transcriptome analysis reveals tumor microenvironment changes in glioblastoma Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Cancer Cell Neuro-oncologyGliomaTumor HeterogeneityBetter UnderstandingSingle Cell Sequencing	2023	231
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study Kaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, Journal of Clinical Oncology	2019	110
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients Kaspar Draaisma, Maarten M.J. Wijnenga, Bas Weenink, Acta Neuropathologica Communications	2015	66
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens Bas Weenink, Kaspar Draaisma, Han Zi Ooi, Scientific Reports	2019	55
The <i>EGFRvIII</i> transcriptome in glioblastoma: A meta-omics analysis Youri Hoogstrate, Santoesha A. Ghisai, Maurice de Wit, Neuro-Oncology	2021	32
Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma—Multivariable Analysis of 497 Patients Sybren L. N. Maas, Kaspar Draaisma, Tom J. Snijders, World Neurosurgery Neuro-oncologyPrognostic BiomarkersPrognostic EvaluationMedicinePrognosis	2019	22
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas Wesley S. van de Geer, Youri Hoogstrate, Kaspar Draaisma, Neuro-Oncology Advances	2021	11

Page 1